Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Wigle

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Pacing and Clinical Electrophysiology : PACE|September 1, 1980
Computer-assisted reporting system for the follow-up patients with cardiac pacemakersD C MacGregor, H D Covvey, E J Noble, et al.
Journal of the American College of Cardiology|January 1, 1989
Aortic regurgitation: a common complication after surgery for hypertrophic obstructive cardiomyopathyZ Sasson, T Prieur, Y Skrobik, et al.
Circulation|October 1, 1995
Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathyM Lechin, M A Quiñones, A Omran, et al.
Heart (British Cardiac Society)|September 17, 2003
Mutations of the beta myosin heavy chain gene in hypertrophic cardiomyopathy: critical functional sites determine prognosisA Woo, H Rakowski, J C Liew, et al.
Canadian Medical Association Journal|September 21, 1974
Late results of aortocoronary bypass grafts in 100 patients with stable angina pectorisJ Morch, B Morton, P McLaughlin, et al.
The New England Journal of Medicine|December 7, 2000
Mutations in sarcomere protein genes as a cause of dilated cardiomyopathyM Kamisago, S D Sharma, S R DePalma, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|January 28, 1998
Role of candidate modifier genes on the phenotypic expression of hypertrophy in patients with hypertrophic cardiomyopathyR Brugada, W Kelsey, M Lechin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2016
Chromoplectic TPM3-ALK rearrangement in a patient with inflammatory myofibroblastic tumor who responded to ceritinib after progression on crizotinibA S Mansfield, S J Murphy, F R Harris, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Pacing and Clinical Electrophysiology : PACE|September 1, 1980
Computer-assisted reporting system for the follow-up patients with cardiac pacemakersD C MacGregor, H D Covvey, E J Noble, et al.
Journal of the American College of Cardiology|January 1, 1989
Aortic regurgitation: a common complication after surgery for hypertrophic obstructive cardiomyopathyZ Sasson, T Prieur, Y Skrobik, et al.
Circulation|October 1, 1995
Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathyM Lechin, M A Quiñones, A Omran, et al.
Heart (British Cardiac Society)|September 17, 2003
Mutations of the beta myosin heavy chain gene in hypertrophic cardiomyopathy: critical functional sites determine prognosisA Woo, H Rakowski, J C Liew, et al.
Canadian Medical Association Journal|September 21, 1974
Late results of aortocoronary bypass grafts in 100 patients with stable angina pectorisJ Morch, B Morton, P McLaughlin, et al.
The New England Journal of Medicine|December 7, 2000
Mutations in sarcomere protein genes as a cause of dilated cardiomyopathyM Kamisago, S D Sharma, S R DePalma, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|January 28, 1998
Role of candidate modifier genes on the phenotypic expression of hypertrophy in patients with hypertrophic cardiomyopathyR Brugada, W Kelsey, M Lechin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2016
Chromoplectic TPM3-ALK rearrangement in a patient with inflammatory myofibroblastic tumor who responded to ceritinib after progression on crizotinibA S Mansfield, S J Murphy, F R Harris, et al.
Pageof 7